Comments
Loading...

HealthEquity Analyst Ratings

HQYNASDAQ
Logo brought to you by Benzinga Data
$111.16
-0.39-0.35%
At close: -
$111.16
0.000.00%
After Hours: 4:00 PM EDT
Q1 2026 Earnings were released on Tue Jun 3rd, after the market close
The most recent conference call was at 16:30 PM, 6 days ago Click to view past webcast
Consensus Rating1
Outperform
Highest Price Target1
$130.00
Lowest Price Target1
$77.00
Consensus Price Target1
$111.24

HealthEquity Analyst Ratings and Price Targets | NASDAQ:HQY | Benzinga

HealthEquity Inc has a consensus price target of $111.24 based on the ratings of 17 analysts. The high is $130 issued by BTIG on November 14, 2024. The low is $77 issued by Goldman Sachs on October 21, 2022. The 3 most-recent analyst ratings were released by Barrington Research, Deutsche Bank, and Goldman Sachs on June 5, 2025, June 5, 2025, and June 4, 2025, respectively. With an average price target of $114.67 between Barrington Research, Deutsche Bank, and Goldman Sachs, there's an implied 3.15% upside for HealthEquity Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
2
Feb
4
1
Mar
2
Apr
1
May
4
1
Jun
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.3
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Barrington Research
Deutsche Bank
Goldman Sachs
RBC Capital
B of A Securities

1calculated from analyst ratings

Analyst Ratings for HealthEquity

Buy NowGet Alert
06/05/2025Buy Now12.45%Barrington Research
Alexander Paris86%
$112 → $125MaintainsOutperformGet Alert
06/05/2025Buy Now3.45%Deutsche Bank
George Hill61%
$98 → $115MaintainsBuyGet Alert
06/04/2025Buy Now-6.44%Goldman Sachs
David Roman40%
$94 → $104MaintainsNeutralGet Alert
06/04/2025Buy Now5.25%RBC Capital
Daniel Perlin58%
$112 → $117MaintainsOutperformGet Alert
06/04/2025Buy Now12.45%B of A Securities
Allen Lutz55%
$110 → $125MaintainsBuyGet Alert
06/04/2025Buy Now5.25%JMP Securities
Constantine Davides41%
$110 → $117MaintainsMarket OutperformGet Alert
05/22/2025Buy Now0.76%RBC Capital
Daniel Perlin58%
→ $112Assumes → OutperformGet Alert
04/16/2025Buy Now-10.04%Keybanc
Scott Schoenhaus48%
$110 → $100MaintainsOverweightGet Alert
04/11/2025Buy Now0.76%Barrington Research
Alexander Paris86%
$112 → $112MaintainsOutperformGet Alert
03/27/2025Buy Now-15.44%Goldman Sachs
David Roman40%
$107 → $94MaintainsNeutralGet Alert
03/25/2025Buy Now3.45%Raymond James
C. Gregory Peters79%
$120 → $115UpgradeOutperform → Strong BuyGet Alert
03/24/2025Buy Now-1.04%Keybanc
Scott Schoenhaus48%
$120 → $110MaintainsOverweightGet Alert
03/19/2025Buy Now0.76%Barrington Research
Alexander Paris86%
$112 → $112MaintainsOutperformGet Alert
03/14/2025Buy Now0.76%Barrington Research
Alexander Paris86%
$112 → $112MaintainsOutperformGet Alert
02/26/2025Buy Now12.45%Wells Fargo
Stan Berenshteyn47%
$110 → $125MaintainsOverweightGet Alert
02/25/2025Buy Now7.95%Raymond James
C. Gregory Peters79%
$105 → $120MaintainsOutperformGet Alert
12/10/2024Buy Now-3.74%JMP Securities
Constantine Davides41%
$105 → $107MaintainsMarket OutperformGet Alert
12/10/2024Buy Now-5.54%RBC Capital
Sean Dodge47%
$100 → $105MaintainsOutperformGet Alert
12/04/2024Buy Now13.35%Mizuho
Steven Valiquette63%
→ $126Initiates → OutperformGet Alert
12/02/2024Buy Now7.95%Barrington Research
Alexander Paris86%
$105 → $120MaintainsOutperformGet Alert
11/15/2024Buy Now-2.84%Goldman Sachs
David Roman40%
→ $108Initiates → NeutralGet Alert
11/14/2024Buy Now16.95%BTIG
David Larsen47%
$110 → $130MaintainsBuyGet Alert
11/13/2024Buy Now7.95%B of A Securities
Allen Lutz55%
$100 → $120MaintainsBuyGet Alert
09/20/2024Buy Now-5.54%Barrington Research
Alexander Paris86%
$105 → $105MaintainsOutperformGet Alert
09/04/2024Buy Now-5.54%Barrington Research
Alexander Paris86%
$105 → $105MaintainsOutperformGet Alert
09/04/2024Buy Now-7.34%Deutsche Bank
George Hill61%
$102 → $103MaintainsBuyGet Alert
09/04/2024Buy Now-5.54%JMP Securities
Constantine Davides41%
$105 → $105ReiteratesMarket Outperform → Market OutperformGet Alert
09/04/2024Buy Now-17.24%RBC Capital
Sean Dodge47%
$92 → $92ReiteratesOutperform → OutperformGet Alert
09/04/2024Buy Now-10.04%B of A Securities
Allen Lutz55%
$105 → $100MaintainsBuyGet Alert
08/30/2024Buy Now-5.54%Barrington Research
Alexander Paris86%
$105 → $105MaintainsOutperformGet Alert
07/03/2024Buy Now-5.54%B of A Securities
Allen Lutz55%
$105 → $105MaintainsBuyGet Alert
06/20/2024Buy Now-1.04%Wells Fargo
Stan Berenshteyn47%
$107 → $110MaintainsOverweightGet Alert
06/07/2024Buy Now-5.54%Raymond James
C. Gregory Peters79%
$100 → $105MaintainsOutperformGet Alert
06/05/2024Buy Now-10.04%Keybanc
Scott Schoenhaus48%
$95 → $100MaintainsOverweightGet Alert
06/04/2024Buy Now-3.74%Wells Fargo
Stan Berenshteyn47%
$105 → $107MaintainsOverweightGet Alert
06/04/2024Buy Now-5.54%Barrington Research
Alexander Paris86%
$100 → $105MaintainsOutperformGet Alert
06/04/2024Buy Now-17.24%RBC Capital
Sean Dodge47%
$92 → $92ReiteratesOutperform → OutperformGet Alert
06/04/2024Buy Now-5.54%B of A Securities
Allen Lutz55%
$97 → $105MaintainsBuyGet Alert
06/04/2024Buy Now-5.54%JMP Securities
Constantine Davides41%
$101 → $105MaintainsMarket OutperformGet Alert
06/04/2024Buy Now-6.44%Baird
Mark Marcon72%
$98 → $104MaintainsOutperformGet Alert
04/04/2024Buy Now-9.14%JMP Securities
Constantine Davides41%
→ $101Initiates → Market OutperformGet Alert
04/02/2024Buy Now-2.84%JP Morgan
Anne Samuel52%
$86 → $108MaintainsOverweightGet Alert
03/22/2024Buy Now-14.54%Keybanc
Scott Schoenhaus48%
$85 → $95MaintainsOverweightGet Alert
03/22/2024Buy Now-10.04%Barrington Research
Alexander Paris86%
→ $100MaintainsOutperformGet Alert
03/20/2024Buy Now-1.04%BTIG
David Larsen47%
$100 → $110MaintainsBuyGet Alert
03/20/2024Buy Now-17.24%RBC Capital
Sean Dodge47%
$90 → $92MaintainsOutperformGet Alert
03/20/2024Buy Now-12.74%B of A Securities
Allen Lutz55%
$93 → $97MaintainsBuyGet Alert
02/23/2024Buy Now-19.04%RBC Capital
Sean Dodge47%
$77 → $90MaintainsOutperformGet Alert
02/23/2024Buy Now-6.44%Barclays—$84 → $104MaintainsOverweightGet Alert
12/13/2023Buy Now-14.54%Raymond James
C. Gregory Peters79%
$90 → $95MaintainsOutperformGet Alert
12/06/2023Buy Now-16.34%Wells Fargo
Stan Berenshteyn47%
$89 → $93MaintainsOverweightGet Alert
12/04/2023Buy Now-23.53%Barrington Research
Alexander Paris86%
→ $85ReiteratesOutperform → OutperformGet Alert
12/01/2023Buy Now-34.33%JP Morgan
Anne Samuel52%
$81 → $73MaintainsOverweightGet Alert
09/21/2023Buy Now-21.73%Baird
Mark Marcon72%
$79 → $87UpgradeNeutral → OutperformGet Alert
09/07/2023Buy Now-35.23%Deutsche Bank
George Hill61%
$71 → $72MaintainsBuyGet Alert
09/06/2023Buy Now-23.53%Barrington Research
Alexander Paris86%
$80 → $85ReiteratesOutperform → OutperformGet Alert
09/06/2023Buy Now-30.73%RBC Capital
Sean Dodge47%
$75 → $77MaintainsOutperformGet Alert
06/07/2023Buy Now-36.13%Deutsche Bank
George Hill61%
$69 → $71MaintainsBuyGet Alert
06/06/2023Buy Now-32.53%RBC Capital
Sean Dodge47%
→ $75Reiterates → OutperformGet Alert
06/01/2023Buy Now-28.03%Barrington Research
Alexander Paris86%
→ $80ReiteratesOutperform → OutperformGet Alert
03/24/2023Buy Now-37.93%Deutsche Bank
George Hill61%
$72 → $69MaintainsBuyGet Alert
03/22/2023Buy Now-28.03%Barrington Research
Alexander Paris86%
→ $80Reiterates → OutperformGet Alert
03/22/2023Buy Now-32.53%RBC Capital
Sean Dodge47%
→ $75Reiterates → OutperformGet Alert
02/03/2023Buy Now-19.94%Wells Fargo
Stan Berenshteyn47%
$101 → $89MaintainsOverweightGet Alert
01/24/2023Buy Now-35.23%Deutsche Bank
George Hill61%
$68 → $72MaintainsBuyGet Alert
12/12/2022Buy Now-23.53%Raymond James
C. Gregory Peters79%
$75 → $85MaintainsOutperformGet Alert
12/07/2022Buy Now-15.44%Guggenheim
Sandy Draper73%
$89 → $94MaintainsBuyGet Alert
12/07/2022Buy Now-9.14%Wells Fargo
Stan Berenshteyn47%
$104 → $101MaintainsOverweightGet Alert
12/05/2022Buy Now-32.53%RBC Capital
Sean Dodge47%
$70 → $75MaintainsOutperformGet Alert
10/25/2022Buy Now-6.44%Wells Fargo
Stan Berenshteyn47%
$100 → $104MaintainsOverweightGet Alert
10/21/2022Buy Now-30.73%Goldman Sachs
Cindy Motz21%
$64 → $77UpgradeSell → NeutralGet Alert
09/16/2022Buy Now-23.53%Keybanc
Scott Schoenhaus48%
→ $85Initiates → OverweightGet Alert
09/13/2022Buy Now-10.04%Wells Fargo
Stan Berenshteyn47%
$95 → $100MaintainsOverweightGet Alert
09/12/2022Buy Now-32.53%Raymond James
C. Gregory Peters79%
$70 → $75MaintainsOutperformGet Alert
09/08/2022Buy Now-38.83%Deutsche Bank
George Hill61%
$67 → $68MaintainsBuyGet Alert
09/07/2022Buy Now-39.73%Baird
Mark Marcon72%
$47 → $67MaintainsNeutralGet Alert
07/12/2022Buy Now-46.92%Goldman Sachs
Cindy Motz21%
→ $59Initiates → SellGet Alert

FAQ

Q

What is the target price for HealthEquity (HQY) stock?

A

The latest price target for HealthEquity (NASDAQ:HQY) was reported by Barrington Research on June 5, 2025. The analyst firm set a price target for $125.00 expecting HQY to rise to within 12 months (a possible 12.45% upside). 32 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for HealthEquity (HQY)?

A

The latest analyst rating for HealthEquity (NASDAQ:HQY) was provided by Barrington Research, and HealthEquity maintained their outperform rating.

Q

When was the last upgrade for HealthEquity (HQY)?

A

The last upgrade for HealthEquity Inc happened on March 25, 2025 when Raymond James raised their price target to $115. Raymond James previously had an outperform for HealthEquity Inc.

Q

When was the last downgrade for HealthEquity (HQY)?

A

There is no last downgrade for HealthEquity.

Q

When is the next analyst rating going to be posted or updated for HealthEquity (HQY)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of HealthEquity, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for HealthEquity was filed on June 5, 2025 so you should expect the next rating to be made available sometime around June 5, 2026.

Q

Is the Analyst Rating HealthEquity (HQY) correct?

A

While ratings are subjective and will change, the latest HealthEquity (HQY) rating was a maintained with a price target of $112.00 to $125.00. The current price HealthEquity (HQY) is trading at is $111.16, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch